nifedipine has been researched along with suramin in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (40.74) | 18.2507 |
| 2000's | 10 (37.04) | 29.6817 |
| 2010's | 5 (18.52) | 24.3611 |
| 2020's | 1 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Mallard, NJ; Marshall, RW; Sithers, AJ; Spriggs, TL | 1 |
| Mallard, N; Marshall, R; Sithers, A; Spriggs, B | 1 |
| Giachetti, A; Maggi, CA; Santicioli, P; Zagorodnyuk, V | 1 |
| Galligan, JJ; Harpstead, T; Herring, A | 1 |
| Bültmann, R; Cunnane, TC; Driessen, B; Elrick, DB; Starke, K; von Kügelgen, I | 1 |
| Bültmann, R; Starke, K | 1 |
| Kurz, K; Starke, K; von Kügelgen, I | 1 |
| Furukawa, T; Katsuragi, T; Usune, S | 1 |
| Hirst, GD; Reilly, MJ | 1 |
| Carabelli, V; Carbone, E; Carra, I | 1 |
| Drmota, T; Krůsek, J; Novotný, J; Svoboda, P | 1 |
| Kwan, CY; Shen, JZ; Zheng, XF | 1 |
| Boselli, C; Grana, E | 1 |
| Chen, L; Cho, H; Harada, N; Nagata, N; Tomoda, K; Yamashita, T | 1 |
| Leite, M; Rohatgi, R; Satlin, LM; Woda, CB | 1 |
| Cleary, L; Docherty, JR; Vandeputte, C | 1 |
| Fanò, G; Guarnieri, S; Mariggiò, MA; Rathbone, MP | 1 |
| Avellar, MC; Caricati-Neto, A; Jurkiewicz, A; Jurkiewicz, NH; Reuter, HR; Verde, LF | 1 |
| Chow, JY; Dong, H; Dong, X; Insel, PA; Kim, HD; Ko, KH; Lee, J; Smoll, EJ | 1 |
| Gao, J; Gui, Y; Li, JJ; Sun, X; Walsh, MP; Wang, Z; Zheng, XL | 1 |
| Hu, J; Huang, C; Lin, AH; Paudel, O; Ran, P; Sham, JS; Subedi, KP | 1 |
| Dai, G; Jia, Z; Li, J; Li, X; Liu, J; Niu, B; Sun, W; Wang, H; Wang, Y; Wu, X; Ye, R; Zhao, Z | 1 |
| Fountain, SJ; Gonzalez-Montelongo, MDC | 1 |
27 other study(ies) available for nifedipine and suramin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Separation of putative alpha 1A- and alpha 1B-adrenoceptor mediated components in the tension response of the rat vas deferens to electrical field stimulation.
Topics: Animals; Clonidine; Electric Stimulation; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Nifedipine; Norepinephrine; Prazosin; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Suramin; Vas Deferens | 1992 |
Suramin: a selective inhibitor of purinergic neurotransmission in the rat isolated vas deferens.
Topics: Adenosine Triphosphate; Animals; Electric Stimulation; In Vitro Techniques; Male; Muscle Contraction; Nifedipine; Norepinephrine; Purinergic Antagonists; Rats; Rats, Wistar; Suramin; Synaptic Transmission; Vas Deferens | 1992 |
Evidence that tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitation and contraction in the circular muscle of guinea-pig duodenum.
Topics: Action Potentials; Adenosine Diphosphate; Animals; Apamin; Arginine; Atropine; Dose-Response Relationship, Drug; Duodenum; Electric Stimulation; Guanethidine; Guinea Pigs; Indomethacin; Muscle Contraction; Muscle, Smooth; Neurokinin A; Neurokinin-1 Receptor Antagonists; Neuromuscular Junction; Nifedipine; Nitroarginine; Oligopeptides; Peptide Fragments; Peptides, Cyclic; Physalaemin; Receptors, Neurokinin-1; Receptors, Neurokinin-2; Substance P; Suramin; Thionucleotides | 1995 |
Pharmacological characterization of purinoceptor-mediated constriction of submucosal arterioles in guinea pig ileum.
Topics: Adenosine Triphosphate; Animals; Arterioles; Calcium; Calcium Channel Blockers; Guinea Pigs; Ileum; Intestinal Mucosa; Nifedipine; Purinergic Agonists; Purinergic Antagonists; Pyridoxal Phosphate; Receptors, Purinergic; Suramin; Vasoconstrictor Agents | 1995 |
The fade of the purinergic neurogenic contraction of the guinea-pig vas deferens: analysis of possible mechanisms.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Calcium Channels; Electric Stimulation; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Nifedipine; Norepinephrine; Prazosin; Receptors, Purinergic; Suramin; Triazines; Vas Deferens | 1994 |
Evans blue blocks P2X-purinoceptors in rat vas deferens.
Topics: Adenosine Triphosphate; Animals; Evans Blue; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Nifedipine; Norepinephrine; Potassium; Purinergic P2 Receptor Antagonists; Rats; Rats, Wistar; Suramin; Vas Deferens | 1993 |
Axon terminal P2-purinoceptors in feedback control of sympathetic transmitter release.
Topics: Adenosine Triphosphate; Animals; Axons; Desipramine; Drug Interactions; Feedback; GTP-Binding Proteins; Male; Mice; Nifedipine; Norepinephrine; Prazosin; Purinergic Antagonists; Receptors, Purinergic; Suramin; Sympathetic Nervous System; Triazines; Vas Deferens; Virulence Factors, Bordetella; Xanthines; Yohimbine | 1993 |
Effects of PPADS and suramin on contractions and cytoplasmic Ca2+ changes evoked by AP4A, ATP and alpha, beta-methylene ATP in guinea-pig urinary bladder.
Topics: Adenosine Triphosphate; Calcium; Calcium Channel Blockers; Cytoplasm; Dinucleoside Phosphates; In Vitro Techniques; Muscle Contraction; Nifedipine; Pyridoxal Phosphate; Suramin; Urinary Bladder | 1996 |
Differences in the responses to purinergic nerve stimulation and applied ATP in the guinea-pig vas deferens.
Topics: Adenosine Triphosphate; Animals; Dose-Response Relationship, Drug; Electric Stimulation; Guinea Pigs; Male; Membrane Potentials; Nifedipine; Suramin; Vas Deferens | 1996 |
Localized secretion of ATP and opioids revealed through single Ca2+ channel modulation in bovine chromaffin cells.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adenosine Triphosphate; Analgesics; Analgesics, Opioid; Animals; Antineoplastic Agents; Autocrine Communication; Barium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Calcium Channels, N-Type; Cattle; Chromaffin Cells; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Exocytosis; Ion Channel Gating; Naloxone; Narcotic Antagonists; Neurotransmitter Agents; Nifedipine; omega-Agatoxin IVA; omega-Conotoxin GVIA; Opioid Peptides; Patch-Clamp Techniques; Peptides; Receptors, Opioid; Receptors, Purinergic; Spider Venoms; Suramin; Virulence Factors, Bordetella | 1998 |
Overexpression of the G protein G11alpha prevents desensitization of Ca2+ response to thyrotropin-releasing hormone.
Topics: Animals; Bradykinin; Calcium; Calcium Channel Blockers; Calcium Signaling; Cell Line; Dose-Response Relationship, Drug; Egtazic Acid; Gene Expression; GTP-Binding Proteins; Humans; Inositol Phosphates; Nifedipine; Rats; Receptors, Thyrotropin-Releasing Hormone; Suramin; Thapsigargin; Thyrotropin-Releasing Hormone; Time Factors; Transfection | 1999 |
Evidence for P(2)-purinoceptors contribution in H(2)O(2)-induced contraction of rat aorta in the absence of endothelium.
Topics: Adenosine Triphosphate; Alkaloids; Analysis of Variance; Animals; Aorta; Apyrase; Benzylisoquinolines; Calcium; Calcium Channel Blockers; Catalase; Dantrolene; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Evans Blue; Hydrogen Peroxide; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Nickel; Nifedipine; Procaine; Purinergic P2 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Signal Transduction; Superoxide Dismutase; Suramin; Triazines; Vasoconstrictor Agents | 2000 |
Differential effects of drugs interacting with autonomic transmitters on responses of rat vas deferens to field stimulation.
Topics: Adrenergic alpha-Antagonists; Animals; Calcium Channel Blockers; Drug Interactions; Electric Stimulation; Male; Muscle Contraction; Neurotransmitter Agents; Nifedipine; Prazosin; Rats; Rats, Wistar; Suramin; Vas Deferens; Vasodilator Agents; Verapamil | 2000 |
Extracellular adenosine 5'-ATP-induced calcium signaling in isolated vestibular ganglion cells of the guinea pig.
Topics: Adenosine Triphosphate; Animals; Calcium; Calcium Channel Blockers; Calcium Signaling; Calcium-Transporting ATPases; Cochlea; Enzyme Inhibitors; Extracellular Space; Fluorescence; Guinea Pigs; Humans; Immunohistochemistry; Neurons, Afferent; Nifedipine; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Spiral Ganglion; Suramin; Time Factors; Triazines; Vestibule, Labyrinth | 2000 |
Effects of luminal flow and nucleotides on [Ca(2+)](i) in rabbit cortical collecting duct.
Topics: Adenosine Triphosphate; Animals; Boron Compounds; Calcium; Calcium Channels, L-Type; Female; Gap Junctions; Kidney Cortex; Kidney Tubules, Collecting; Nifedipine; Nucleotides; Purinergic P2 Receptor Antagonists; Rabbits; Receptors, Purinergic P2; Suramin; Thapsigargin; Uridine Triphosphate | 2002 |
Investigation of postjunctional alpha1- and alpha2-adrenoceptor subtypes in vas deferens from wild-type and alpha(2A/D)-adrenoceptor knockout mice.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Cocaine; Electric Stimulation; Imidazoles; Indoles; Isoindoles; Isometric Contraction; Male; Mice; Mice, Knockout; Nifedipine; Norepinephrine; Phenylephrine; Piperazines; Prazosin; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Purinergic; Suramin; Thymine; Vas Deferens; Yohimbine | 2003 |
Cooperation in signal transduction of extracellular guanosine 5' triphosphate and nerve growth factor in neuronal differentiation of PC12 cells.
Topics: Animals; Barbiturates; Blotting, Western; Calcium; Calcium Channel Blockers; Cell Count; Cell Differentiation; Chelating Agents; Clotrimazole; Diagnostic Imaging; Dose-Response Relationship, Drug; Drug Synergism; Egtazic Acid; Enzyme Inhibitors; Extracellular Space; Fluorescent Antibody Technique; Fluorescent Dyes; Gallic Acid; Growth Inhibitors; Guanosine Triphosphate; Ionomycin; Ionophores; Isoxazoles; Membrane Potentials; Microscopy, Confocal; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nerve Growth Factor; Neurites; Nifedipine; PC12 Cells; Pertussis Toxin; Pyridoxal Phosphate; Rats; Signal Transduction; Suramin; Time Factors; Triazines | 2004 |
Sympathetic neurotransmission in the rat testicular capsule: functional characterization and identification of mRNA encoding alpha1-adrenoceptor subtypes.
Topics: Acetyl-CoA C-Acyltransferase; Adenosine Triphosphate; Adrenergic alpha-Antagonists; Adrenergic Uptake Inhibitors; Animals; Calcium Channel Blockers; Clonidine; Dioxanes; Dose-Response Relationship, Drug; Electric Stimulation; Male; Muscle Contraction; Nifedipine; Norepinephrine; Prazosin; Purinergic P2 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Purinergic P2; Reserpine; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spiperone; Suramin; Sympathetic Nervous System; Synaptic Transmission; Testis | 2006 |
P2Y receptors mediate Ca2+ signaling in duodenocytes and contribute to duodenal mucosal bicarbonate secretion.
Topics: Adenosine Diphosphate; Aminoquinolines; Animals; Bicarbonates; Boron Compounds; Calcium Channel Blockers; Calcium Signaling; Cell Line; Dogs; Duodenum; Epithelial Cells; Estrenes; Female; Hydrogen-Ion Concentration; Intestinal Mucosa; Intestinal Secretions; Membrane Potentials; Mice; Mice, Inbred C57BL; Mice, Knockout; Nifedipine; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Pyrrolidinones; Receptors, Purinergic P2; Receptors, Purinergic P2Y2; Suramin; Time Factors; Uridine Triphosphate | 2009 |
Uridine adenosine tetraphosphate induces contraction of airway smooth muscle.
Topics: Animals; Bronchi; Calcium; Calcium Channels, L-Type; Dinucleoside Phosphates; Male; Muscle Contraction; Muscle, Smooth; Myography; Nifedipine; Protein Kinase Inhibitors; Purinergic P2X Receptor Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Receptors, Purinergic P2X; Receptors, Purinergic P2Y; Reverse Transcriptase Polymerase Chain Reaction; rho-Associated Kinases; Signal Transduction; Suramin; Trachea | 2011 |
Extracellular Adenosine Diphosphate Ribose Mobilizes Intracellular Ca2+ via Purinergic-Dependent Ca2+ Pathways in Rat Pulmonary Artery Smooth Muscle Cells.
Topics: Adenosine Diphosphate Ribose; Adenosine Triphosphate; Animals; Calcium; Calcium Signaling; Cells, Cultured; Estrenes; Imidazoles; Ions; Male; Myocytes, Smooth Muscle; Nifedipine; Pulmonary Artery; Purinergic P2X Receptor Antagonists; Purinergic P2Y Receptor Antagonists; Pyrrolidinones; Rats; Rats, Wistar; Receptors, Purinergic P2X; Receptors, Purinergic P2Y1; Signal Transduction; Suramin; TRPM Cation Channels; Type C Phospholipases | 2015 |
Adenosine Triphosphate (ATP) Inhibits Voltage-Sensitive Potassium Currents in Isolated Hensen's Cells and Nifedipine Protects Against Noise-Induced Hearing Loss in Guinea Pigs.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Calcium; Calcium Channel Blockers; Guinea Pigs; Hair Cells, Auditory; Hearing Loss, Noise-Induced; Nifedipine; Organ of Corti; Patch-Clamp Techniques; Potassium Channels, Voltage-Gated; Random Allocation; Signal Transduction; Suramin | 2016 |
Neuropeptide Y facilitates P2X1 receptor-dependent vasoconstriction via Y1 receptor activation in small mesenteric arteries during sympathetic neurogenic responses.
Topics: Adenosine Triphosphate; Adrenergic alpha-1 Receptor Antagonists; Animals; Benzenesulfonates; Calcium Channel Blockers; Calcium Channels, L-Type; Male; Mesenteric Arteries; Mice, Inbred C57BL; Neuropeptide Y; Nifedipine; Prazosin; Receptors, Neuropeptide Y; Receptors, Purinergic P2X1; Suramin; Sympathetic Nervous System; Vasoconstriction | 2021 |